Form 4: Staar Surgical Appoints Arthur Butcher to Board of Directors, Grants Equity Compensation

Arthur Butcher joins Staar Surgical's Board of Directors and receives equity compensation in the form of restricted shares and stock options.

Summary

• Arthur Butcher has been appointed to the Board of Directors of Staar Surgical, effective March 12, 2024.
• As a non-employee director, Mr. Butcher received 649 restricted shares of common stock.
• He was also granted options to purchase 1,163 shares of common stock.
• The equity compensation represents a pro-rated amount of the standard director equity compensation for the 2023-2024 term.
• The restricted shares and stock options vest in full on the earlier of June 20, 2024, or the Corporation's 2024 Annual Meeting of Shareholders.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The appointment of a new board member is generally viewed as a positive development, and the equity grant aligns the director's interests with those of shareholders.

Positives

• The appointment of a new board member could bring fresh perspectives and expertise to Staar Surgical.
• The granting of equity compensation aligns Mr. Butcher's interests with those of the shareholders.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the equity grants.

Industry Context

Board appointments and equity grants are standard practice in publicly traded companies to attract and retain qualified directors. The size and terms of the grant appear typical for a non-employee director.

Comparison to Industry Standards

• Director compensation packages typically include a mix of cash and equity.
• The number of shares and options granted to Mr. Butcher is likely benchmarked against peer companies in the medical device industry.
• Comparable companies such as Alcon, Johnson & Johnson (medical device segment), and Bausch + Lomb typically disclose similar director compensation details in their proxy statements.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment positively if Mr. Butcher's expertise benefits the company.
• Employees are unlikely to be directly impacted by this appointment.

Next Steps

• Mr. Butcher will serve on the Board of Directors.
• The restricted shares and stock options will vest according to the specified schedule.

Key Dates